OLpur™ H2H™  provides you
         with:

   
     >   A markedly improved treatment
          modality with on-line production
          of ultrapure substitution fluid
   
     >   Cost effective hemodiafiltration
          therapy without the need to
          replace your current dialysis
          machines
   
     >   Independent operation from the
          dialysis machine, with redundant
          safety features designed to
          provide a safe and effective
          treatment
   
     >   An elegant design that's
          easy-to-learn and simple-to-use  



  Offering our patented technology (patent appl. PCT/US02/03741, PCT/US01
  /47211, PCT/US01/45369) simplified design, and  a  straightforward,  friendly
  user interface. OLpur H2H is slated to  enter the  ESRD  marketplace  in
  the latter part of 2005.

  This product has not yet been approved for sale.

© 2010 Nephros, Inc                                                   Powered by Advisions